Search Results - "GOLDMACHER, Victor S"

Refine Results
  1. 1
  2. 2
  3. 3

    Synthesis and Evaluation of Hydrophilic Linkers for Antibody–Maytansinoid Conjugates by Zhao, Robert Y, Wilhelm, Sharon D, Audette, Charlene, Jones, Gregory, Leece, Barbara A, Lazar, Alexandru C, Goldmacher, Victor S, Singh, Rajeeva, Kovtun, Yelena, Widdison, Wayne C, Lambert, John M, Chari, Ravi V. J

    Published in Journal of medicinal chemistry (26-05-2011)
    “…The synthesis and biological evaluation of hydrophilic heterobifunctional cross-linkers for conjugation of antibodies with highly cytotoxic agents are…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Antibody-maytansinoid conjugates are activated in targeted cancer cells by lysosomal degradation and linker-dependent intracellular processing by ERICKSON, Hans K, PARK, Peter U, WIDDISON, Wayne C, KOVTUN, Yelena V, GARRETT, Lisa M, HOFFMAN, Karen, LUTZ, Robert J, GOLDMACHER, Victor S, BLÄTTLER, Walter A

    Published in Cancer research (Chicago, Ill.) (15-04-2006)
    “…Antibody-drug conjugates are targeted anticancer agents consisting of a cytotoxic drug covalently linked to a monoclonal antibody for tumor antigen-specific…”
    Get full text
    Journal Article
  6. 6

    High-affinity accumulation of a maytansinoid in cells via weak tubulin interaction by Goldmacher, Victor S, Audette, Charlene A, Guan, Yinghua, Sidhom, Eriene-Heidi, Shah, Jagesh V, Whiteman, Kathleen R, Kovtun, Yelena V

    Published in PloS one (11-02-2015)
    “…The microtubule-targeting maytansinoids accumulate in cells and induce mitotic arrest at 250- to 1000-fold lower concentrations than those required for their…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    murine cytomegalovirus cell death suppressor m38.5 binds Bax and blocks Bax-mediated mitochondrial outer membrane permeabilization by Arnoult, Damien, Skaletskaya, Anna, Estaquier, Jérôme, Dufour, Cecilie, Goldmacher, Victor S

    Published in Apoptosis (London) (01-09-2008)
    “…Apoptosis is increasingly implicated as an early line of defense against viral infections. Viruses have devised numerous strategies to delay apoptosis of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    A clinically relevant SCID-hu in vivo model of human multiple myeloma by Tassone, Pierfrancesco, Neri, Paola, Carrasco, Daniel R., Burger, Renate, Goldmacher, Victor S., Fram, Robert, Munshi, Vidit, Shammas, Masood A., Catley, Laurence, Jacob, Gary S., Venuta, Salvatore, Anderson, Kenneth C., Munshi, Nikhil C.

    Published in Blood (15-07-2005)
    “…We developed a novel in vivo multiple myeloma (MM) model by engrafting the interleukin 6 (IL-6)-dependent human MM cell line INA-6 into severe combined…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Cell killing by antibody–drug conjugates by Kovtun, Yelena V, Goldmacher, Victor S

    Published in Cancer letters (08-10-2007)
    “…Abstract Antibody–drug conjugates (ADCs) are designed to specifically bind to and kill cells expressing their target antigens. In addition to the obvious…”
    Get full text
    Journal Article
  18. 18

    Processing of Human Cytomegalovirus UL37 Mutant Glycoproteins in the Endoplasmic Reticulum Lumen prior to Mitochondrial Importation by Mavinakere, Manohara S, Williamson, Chad D, Goldmacher, Victor S, Colberg-Poley, Anamaris M

    Published in Journal of Virology (01-07-2006)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  19. 19

    Beyond ADCs: harnessing bispecific antibodies to directly induce apoptosis for targeted tumor eradication by Goldmacher, Victor S, Gershteyn, Iosif M, Kovtun, Yelena

    Published in Antibody therapeutics (29-10-2024)
    “…Abstract Bispecific apoptosis triggers (BATs) are innovative bispecific antibodies designed to simultaneously target both a tumor-associated antigen and a…”
    Get full text
    Journal Article
  20. 20

    Statistics of the Distribution of the Abundance of Molecules with Various Drug Loads in Maytansinoid Antibody–Drug Conjugates by Goldmacher, Victor S, Amphlett, Godfrey, Wang, Lintao, Lazar, Alexandru C

    Published in Molecular pharmaceutics (01-06-2015)
    “…The maytansinoid antibody–drug conjugates (ADCs) in clinical development for cancer therapy each contain a derivative of the microtubule-targeting agent,…”
    Get full text
    Journal Article